Literature DB >> 32062954

[A review of combined immunization: current research situation and its promising future].

X M Yang1.   

Abstract

Combined immunization consists of combined vaccines (including polyvalent vaccines) and simultaneous administration of vaccines, aiming to reduce unnecessary inoculating times for children, and to broaden immunization coverage and a significant larger group of population would be benefit from the Expanded Program on Immunization. In this review, we have summarized a list of research papers focused on combined immunization. By scrutinizing the safety and effectiveness outcomes of combined immunization, we provide some suggestions about upgrading the current immunization program as well as research and development of new combined vaccines.

Entities:  

Keywords:  Combined vaccine; Expanded Program on Immunization; Simultaneous administration of vaccines

Mesh:

Substances:

Year:  2020        PMID: 32062954     DOI: 10.3760/cma.j.issn.0254-6450.2020.01.022

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.

Authors:  Xiaoyu Liu; Wanqi Yang; Chao Zhang; Heng Wu; Ruize Wang; Qiang Ding; Yan Hu; Yongli Xiong; Shaobai Zhang; Lin Wang
Journal:  Hum Vaccin Immunother       Date:  2021-12-14       Impact factor: 3.452

2.  The development of China's vaccine industry in the past decade: the perspective from drug regulatory science.

Authors:  Guanjie Wang; Mingli Shao
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 3.  Effect of Immune Stress on Growth Performance and Immune Functions of Livestock: Mechanisms and Prevention.

Authors:  Xueting Niu; Yuexia Ding; Shengwei Chen; Ravi Gooneratne; Xianghong Ju
Journal:  Animals (Basel)       Date:  2022-04-02       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.